Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abnormal, absorb, accidental, aforementioned, allele, alliance, Allo, Alnylam, alongside, amplified, anesthesiologist, answer, arm, ATMP, attached, ATTRv, ATTRwt, AvenCell, baseline, Basta, beneficiary, BioCryst, Blackstone, bloodstream, Bookmark, Boston, BridgeBio, bridging, Britain, broadest, Canada, Carolina, CAT, caution, CDPA, Cellex, certified, cHL, CHMP, circumstance, Clark, classical, clean, clock, coagulation, Colorado, commandeered, commensurate, compulsory, condensed, conference, configuration, contrary, Council, counterparty, CPA, CPRA, CSL, CTCL, customary, cytosine, deaminase, Derek, difficulty, dossier, editor, Eliana, elucidate, emphysema, England, Epigenome, eSymposium, explanation, flurry, foci, forefront, frame, GEMoaB, genotype, GmbH, goodwill, governor, Great, hacking, harmonized, Hem, heterogeneity, HIV, Hodgkin, Iceland, ID, immediacy, inactivate, inconsistent, inflammatory, input, insolvency, investee, invoice, invoiced, Ireland, Jersey, joining, Keystone, killer, knockdown, Kyverna, LCA, Liechtenstein, Likewise, lymphatic, magnitude, MEDSAFE, memo, merged, mix, mixture, moiety, mutant, mutual, Nerve, neurodegenerative, NK, NOL, noncash, noncontrolling, Nordisk, North, Norway, notably, Ohio, ONK, outlook, pair, pause, peer, Pennsylvania, pertinent, Pfizer, Pharming, plausible, PNS, poorer, portal, predetermined, prepayment, presence, profound, prominent, proteinase, PTCL, quick, ransomware, readout, reassessed, reconsideration, reevaluate, residual, resurgence, retina, RevCAR, revoked, revolution, Rewrite, room, RSU, run, RW, SAS, saving, scenario, Secretary, securityholder, serine, shielded, SparingVision, SPC, specialist, staying, supplier, suppression, Sweden, switchable, synthesized, SZ, Takeda, TCA, toolbox, tracing, Transcriptome, translocation, Treasurer, Tudor, underwritten, undisclosed, uneven, UniCAR, unrestricted, upcoming, vaccinate, venture, verification, verify, version, VIE, viewpoint, Virginia, vision, voluntarily, Waltham, wholesale, Winter, witnessed, younger, ZZ
Removed:
adapting, adjudicated, advancement, Andrew, clarifying, clearance, consult, entirety, estate, forfeited, hATTR, IIa, IIb, Jos, lab, limbal, manufacturability, MilliporeSigma, Mine, organizing, outlined, path, phenotype, predominantly, principally, ranging, real, resolved, retrospective, Rivera, Schiermeier, underway, wtATTR
Filing tables
Filing exhibits
Related press release
Associated NTLA transcripts
NTLA similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-233448 and 333-251022 on Form S-3 and Registration Statement Nos. 333-211200, 333-218511, 333-229900, 333-236714 and 333-253562 on Form S-8 of our reports dated February 24, 2022, relating to the financial statements of Intellia Therapeutics, Inc., and the effectiveness of Intellia Therapeutics, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2021.
|
|
|
/s/ Deloitte & Touche LLP
|
Boston, Massachusetts |
February 24, 2022 |